Australia's LTR Pharma rises on securing stake in LevOmega

Ltr Pharma

22/09/2025 01:25

** Shares of Australia's LTR Pharma LTP.AX up 4.8% at A$0.77

** Stock rises as much as 10.2%, hitting its highest level since January 31

** Biopharmaceutical firm secures 33% equity stake in LevOmega at nil cost to shareholders

** LevOmega is an Australian operating company focused on development of nature-identical omega-3 product - LTP

** Omega-3 product refers to supplement, food, or ingredient that contains omega-3 fatty acids - essential fats that body cannot produce on its own and must obtain through diet

** LTP stock has fallen 9.3% this year, including session gains

(Reporting by Roshan Thomas in Bengaluru)

((Roshan.Thomas@thomsonreuters.com;))